Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chen Guo, Min Li, Yong-Hui Lv, Ming-Bo Zhang & Zhi-Lu Wang. (2020) De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Platelets 31:1, pages 15-25.
Read now
Read now
Aung Myat, Udaya S. Tantry, Jacek Kubica & Paul A. Gurbel. (2016) Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events. Expert Review of Cardiovascular Therapy 14:12, pages 1361-1370.
Read now
Read now
Articles from other publishers (29)
Sukru Akyuz, Ali Nazmi Calik, Baris Yaylak, Tolga Onuk, Semih Eren, Zeynep Kolak, Feyza Mollaalioglu, Furkan Durak, Mustafa Cetin & Ibrahim Halil Tanboga. (2024) Comparison of Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome at High Bleeding or Ischemic Risk. The American Journal of Cardiology 210, pages 241-248.
Crossref
Crossref
Eun Ho Choo, Ik Jun Choi, Sungmin Lim, Donggyu MoonChan Joon KimMahn-Won Park, Min Chul Kim, Byung-Hee HwangKwan Yong Lee, Yun Seok ChoiHee-Yeol KimKi-Dong Yoo, Doo Soo Jeon, Youngkeun Ahn & Kiyuk Chang. (2022) Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction. Circulation: Cardiovascular Interventions 15:12.
Crossref
Crossref
Michael U. Williams, William R. Lang, Tyler Wark, Gerry Ovide, Rei Mitsuyama, Vishnu Kadiyala, Sokunvichet Long, Robert E. Heinl, Mustapha Ousman Kah, Esseim Sharma, Omar N. Hyder, Chirag Bavishi, Kevin F. Kennedy, Herbert Aronow & J. Dawn Abbott. (2022) Predictors of In-Hospital De-Escalation of P2Y12 Inhibitors to Clopidogrel in Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention. Cardiovascular Revascularization Medicine 42, pages 154-158.
Crossref
Crossref
Omer Burak Istanbullu & Gulsen Akdogan. (2021) Influences of Stent Design on In-Stent Restenosis and Major Cardiac Outcomes: A Scoping Review and Meta-Analysis. Cardiovascular Engineering and Technology 13:1, pages 147-169.
Crossref
Crossref
Meng-Jin Hu, Jiang-Shan Tan, Xiao-Jin Gao, Jin-Gang Yang & Yue-Jin Yang. (2022) De-escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: An Updated Meta-analysis and Trial Sequential Analysis of 21 Studies and 38,741 Patients. Journal of Cardiovascular Pharmacology 79:6, pages 873-886.
Crossref
Crossref
Chih-Kuo Lee, Tzung-Dau Wang, Hsiao-Ting Juang, Shu-Chen Chang, Heng-Yu Pan, Donna Shu-Han Lin & Chee-Jen Chang. (2021) Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan. Scientific Reports 11:1.
Crossref
Crossref
Valeria Cammalleri, Michela Bonanni, Francesca Maria Bueti, Andrea Matteucci, Lisa Cammalleri, Giuseppe Stifano, Saverio Muscoli & Francesco Romeo. (2020) Multidimensional Prognostic Index (MPI) in elderly patients with acute myocardial infarction. Aging Clinical and Experimental Research 33:7, pages 1875-1883.
Crossref
Crossref
Seng Chan You, Yeunsook Rho, Behnood Bikdeli, Jiwoo Kim, Anastasios Siapos, James Weaver, Ajit Londhe, Jaehyeong Cho, Jimyung Park, Martijn Schuemie, Marc A. Suchard, David Madigan, George Hripcsak, Aakriti Gupta, Christian G. Reich, Patrick B. Ryan, Rae Woong Park & Harlan M. Krumholz. (2020) Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA 324:16, pages 1640.
Crossref
Crossref
Marieke E. Gimbel, Gerrit J. A. Vos, Thuc A. Nguyen, Johannes C. Kelder & Jurriën M. ten Berg. (2020) Reasons for early discontinuing or switching of antiplatelet therapy in elderly patients after acute coronary syndrome. Coronary Artery Disease 31:1, pages 66-72.
Crossref
Crossref
Jenny Hong, Ricky D. Turgeon & Glen J. Pearson. (2019) Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis. Annals of Pharmacotherapy 53:10, pages 997-1004.
Crossref
Crossref
L. I. Malinova, P. V. Dolotovskaya, N. F. Puchinyan & V. V. Furman. (2019) Intrahospital switch of the P2Y12 inhibitors in patients with ST segment elevation myocardial infarction in ‘real-life’ clinical practice: the effect on the functional activity of thrombocytes and thrombocytopoiesis, prognostic value. Cardiovascular Therapy and Prevention 18:4, pages 25-32.
Crossref
Crossref
Dimitrios Alexopoulos, Ioannis Lianos, Panagiotis Vlachakis, Danai Sfantou, Vassiliki-Maria Dragona & Charalambos Varlamos. (2019) De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives. Journal of Cardiovascular Pharmacology and Therapeutics 24:4, pages 304-314.
Crossref
Crossref
Dominick J. Angiolillo, Giuseppe Patti, Kam Tim Chan, Yaling Han, Wei-Chun Huang, Alexey Yakovlev, Dara Paek, Michael del Aguila, Shalini Girotra & Dirk Sibbing. (2019) De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis 48:1, pages 1-10.
Crossref
Crossref
V. A. Brazhnik, L. O. Minushkina, R. R. Guliev, A. O. Averkova, A. A. Rogozhina, O. S. Koroleva, E. A. Zubova, E. A. Karmanchikova, N. R. Khasanov, M. A. Chichkova, O. I. Boeva, A. S. Galyavich & D. A. Zateyshchikov. (2019) Bleeding risk factors in patients with acute coronary syndrome: data from observational studies ORACUL II. Russian Journal of Cardiology 24:3, pages 7-16.
Crossref
Crossref
Enrico Cerrato, Matteo Bianco, Akshay Bagai, Leonardo De Luca, Simone Biscaglia, Alessia Luciano, Paola Destefanis, Giorgio Quadri, Ilaria Meynet, Carol Gravinese, Alessandra Chinaglia, Shaun G. Goodman, Roberto Pozzi, Gianluca Campo & Ferdinando Varbella. (2019) Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies. IJC Heart & Vasculature 22, pages 39-45.
Crossref
Crossref
Brett Doble, Maria Pufulete, Jessica M. Harris, Tom Johnson, Daniel Lasserson, Barnaby C. Reeves & Sarah Wordsworth. (2018) Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study. Health and Quality of Life Outcomes 16:1.
Crossref
Crossref
Xin-Yun Li, Guo-Hai Su, Guang-Xin Wang, Hong-Yan Hu & Chun-Jie Fan. (2018) Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China: Occurrences, reasons, and long-term clinical outcomes. Clinical Cardiology 41:11, pages 1446-1454.
Crossref
Crossref
Peng Ding, Yujie Wei, Nana Chen & Huiliang Liu. (2017) Validation of a New ELISA-Based Vasodilator-Associated Stimulated Phosphoprotein Phosphorylation Assay to Assess Platelet Reactivity Index in a Chinese Population. Clinical and Applied Thrombosis/Hemostasis 24:3, pages 452-461.
Crossref
Crossref
Philipp Krisai, Manuel Haschke, Peter T. Buser & Christian Mueller. (2017) Ticagrelor induced systemic inflammatory response syndrome. BMC Cardiovascular Disorders 17:1.
Crossref
Crossref
Thomas Cuisset, Pierre Deharo, Jacques Quilici, Thomas W. Johnson, Stéphanie Deffarges, Clémence Bassez, Guillaume Bonnet, Laurent Fourcade, Jean Philippe Mouret, Marc Lambert, Valentine Verdier, Pierre Emmanuel Morange, Marie Christine Alessi & Jean Louis Bonnet. (2017) Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. European Heart Journal 38:41, pages 3070-3078.
Crossref
Crossref
Gianluca Campo, Rita Pavasini, Elisa Maietti, Elisabetta Tonet, Paolo Cimaglia, Giulia Scillitani, Giulia Bugani, Matteo Serenelli, Fatima Zaraket, Cristina Balla, Filippo Trevisan, Simone Biscaglia, Biagio Sassone, Marcello Galvani, Roberto Ferrari & Stefano Volpato. (2016) The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clinical and Experimental Research 29:5, pages 895-903.
Crossref
Crossref
Simone Biscaglia, Elisabetta Tonet, Rita Pavasini, Matteo Serenelli, Giulia Bugani, Paolo Cimaglia, Francesco Gallo, Giosafat Spitaleri, Annamaria Del Franco, Giorgio Aquila, Francesco Vieceli Dalla Sega, Matteo Tebaldi, Carlo Tumscitz, Roberto Ferrari & Gianluca Campo. (2017) A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial. PLOS ONE 12:8, pages e0182124.
Crossref
Crossref
Gianluca Campo, Francesco Vieceli Dalla Sega, Rita Pavasini, Giorgio Aquila, Francesco Gallo, Francesca Fortini, Elisabetta Tonet, Paolo Cimaglia, Annamaria Del Franco, Gabriele Pestelli, Alessandro Pecoraro, Marco Contoli, Cristina Balla, Simone Biscaglia, Paola Rizzo & Roberto Ferrari. (2017) Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thrombosis and Haemostasis 117:06, pages 1208-1216.
Crossref
Crossref
Peter D Larsen, Ana S Holley, Alexander Sasse, Ali Al-Sinan, Sarah Fairley & Scott A Harding. (2017) Comparison of Multiplate and VerifyNow platelet function tests in predicting clinical outcome in patients with acute coronary syndromes. Thrombosis Research 152, pages 14-19.
Crossref
Crossref
Simone Biscaglia, Matteo Tebaldi, Carlo Tumscitz, Rita Pavasini, Jlenia Marchesini, Francesco Gallo, Giosafat Spitaleri, Fatima Zaraket, Matteo Serenelli, Paolo Cimaglia, Giulia Bugani & Gianluca Campo. (2017) Prospective Identification of Stent Fracture by Enhanced Stent Visualization System During Percutaneous Coronary Intervention. Circulation Journal 81:1, pages 82-89.
Crossref
Crossref
Francesco Franchi & Fabiana Rollini. (2017) Switching from ticagrelor to clopidogrel: New answers and further questions. Thrombosis and Haemostasis 117:02, pages 207-208.
Crossref
Crossref
Ali Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, Michel R. Le May, Marino Labinaz, Trevor Simard, F. Daniel Ramirez, Peter Lugomirski, Ronnen Maze, Michael Froeschl, Christopher Glover, Alexander Dick, Jean-Francois Marquis, Jordan Bernick, George Wells & Derek Y. F. So. (2017) A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. Thrombosis and Haemostasis 117:02, pages 303-310.
Crossref
Crossref
Roberto Ferrari & Gianluca Campo. (2017) Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis?. Cardiology 137:4, pages 244-245.
Crossref
Crossref
Peter Held, Anders Himmelmann & Marc Ditmarsch. (2016) Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program. Future Cardiology 12:4, pages 405-418.
Crossref
Crossref